M J Borad, R Swift, J R Berenson. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AgedAntineoplastic Agents, Alkylating/administration & dosageAntineoplastic Agents, Alkylating/adverse effectsArsenic TrioxideArsenicals/administration & dosageArsenicals/adverse effectsAscorbic Acid/administration & dosageAscorbic Acid/adverse effectsFemaleHumansMaleMelphalan/administration & dosageMelphalan/adverse effectsMiddle AgedMultiple Myeloma/drug therapyOxides/administration & dosageOxides/adverse effectsRecurrenceTreatment Outcome
Substances: See more » Antineoplastic Agents, AlkylatingArsenicalsOxidesAscorbic AcidMelphalanArsenic Trioxide
Year: 2005 PMID: 15496977 DOI: 10.1038/sj.leu.2403541
Source DB: PubMed Journal: Leukemia ISSN: 0887-6924 Impact factor: 11.528